Biotech

R&D
LSX World Congress – Day 2 banner image

LSX World Congress – Day Two

On Day Two of 2024's LSX World Congress, we’ll hear about the biotech/biopharma IPO market, the 2024 US Presidential election, and about the future of digital health.

R&D
LSX World Congress – Day 1 banner

LSX World Congress – Day One

Day One will kick off with a couple of sessions on the investing landscape, including one featuring speakers from Google and Eli Lilly.

R&D
LSX World Congress banner

LSX World Congress – Live coverage

At the LSX (Life Sciences Executive) World Congress in Boston, leaders in biotech, healthtech, and medtech will gather to share trends, insights, and strategies for keeping on top of the va

News
Hand holding a pen following the peaks and troughs of a graph on screen

BioAge's $100m IPO, and other biotech financings

Our round-up of financings in the biotech sector this week is led by BioAge Lab's filing of an initial public offering (IPO), with a placeholder target of $100 million, plus sizeable privat